Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.81% is 30% above its 5-year average of 1.40%, near the low end of its 5-year range (0.60%–5.32%).
As of the fiscal period ended Sunday, May 31, 2026. 2.50% below its 12-month average of 1.86%.
Reported quarterly debt to assets ratio; no daily interpolation. Q3 FY2026 (2026-05-31): 1.81%.
DEBT TO ASSETS RATIO
1.81%
DEBT TO ASSETS RATIO AVG TTM
1.86%
DEBT TO ASSETS RATIO AVG 3Y
2.08%
DEBT TO ASSETS RATIO AVG 5Y
1.40%
DEBT TO ASSETS RATIO AVG 10Y
1.42%
DEBT TO ASSETS RATIO AVG 15Y
2.08%
DEBT TO ASSETS RATIO AVG 20Y
11.49%
CURRENT VS TTM AVG
-2.50%
CURRENT VS 3Y AVG
-12.92%
CURRENT VS 5Y AVG
+30.00%
CURRENT VS 10Y AVG
+27.63%
CURRENT VS 15Y AVG
-12.91%
CURRENT VS 20Y AVG
-84.22%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 592 covered companies
CURRENT VS SECTOR MEDIAN
+1713.60%
vs the sector median at left
Lexaria Bioscience Corp.
Market Cap
$4.79M
Debt to Assets Ratio
1.81%
TTM Avg
1.86%
3Y Avg
2.08%
5Y Avg
1.40%
Market Cap
$4.75M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.87M
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.59M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.43M
Debt to Assets Ratio
0.37%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.20M
Debt to Assets Ratio
0.42%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.27M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | $4.79M | 1.81% | 1.86% | 2.08% | 1.40% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.75M | 0.00% | N/A | N/A | N/A |
| CalciMedica, Inc. (CALC)vs › | $4.72M | 0.00% | N/A | N/A | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.87M | 0.25% | N/A | N/A | N/A |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.59M | 0.00% | N/A | N/A | N/A |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.43M | 0.37% | N/A | N/A | N/A |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.20M | 0.42% | N/A | N/A | N/A |
| Imunon, Inc. (IMNN)vs › | $5.21M | 0.52% | N/A | N/A | N/A |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.27M | 0.15% | N/A | N/A | N/A |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.29M | 0.09% | N/A | N/A | N/A |
Debt/Assets
1.8%
Debt/Equity
0.02
Current Ratio
10.60
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-05-31 | 1.81% |
| 2026-02-28 | 1.45% |
| 2025-11-30 | 1.68% |
| 2025-08-31 | 2.62% |
| 2025-05-31 | 1.73% |
| 2025-02-28 | 1.43% |
| 2024-11-30 | 1.33% |
| 2024-08-31 | 1.55% |
| 2024-05-31 | 1.42% |
| 2024-02-29 | 2.34% |
| 2023-11-30 | 4.28% |
| 2023-08-31 | 5.32% |
| 2023-05-31 | 3.34% |
| 2023-02-28 | 0.60% |
| 2022-11-30 | 0.64% |
| 2022-08-31 | 0.64% |
| 2022-05-31 | 0.74% |
| 2022-02-28 | 0.68% |
| 2021-11-30 | 0.75% |
| 2021-08-31 | 0.73% |
| 2021-05-31 | 1.01% |
| 2021-02-28 | 0.95% |
| 2020-11-30 | 6.78% |
| 2020-08-31 | 5.52% |
| 2020-05-31 | 0.87% |
| 2020-02-29 | 0.00% |
| 2019-11-30 | 0.00% |
| 2019-08-31 | 0.00% |
| 2019-05-31 | 0.00% |
| 2019-02-28 | 0.00% |
| 2018-11-30 | 0.00% |
| 2018-08-31 | 0.00% |
| 2018-05-31 | 0.00% |
| 2018-02-28 | 0.00% |
| 2017-11-30 | 0.00% |
| 2017-08-31 | 0.00% |
| 2017-05-31 | 1.43% |
| 2017-02-28 | 5.18% |
| 2016-11-30 | 3.96% |
| 2016-08-31 | 7.94% |
| 2016-05-31 | 13.58% |
| 2016-02-29 | 0.00% |
| 2015-11-30 | 0.00% |
| 2015-08-31 | 0.00% |
| 2015-05-31 | 0.00% |
| 2015-02-28 | 0.00% |
| 2014-11-30 | 0.00% |
| 2014-07-31 | 17.65% |
| 2014-04-30 | 18.80% |
| 2014-01-31 | 36.11% |
| 2013-10-31 | 35.74% |
| 2013-07-31 | 35.26% |
| 2013-04-30 | 36.44% |
| 2013-01-31 | 37.61% |
| 2012-10-31 | 39.18% |
| 2012-07-31 | 39.12% |
| 2012-04-30 | 39.03% |
| 2012-01-31 | 36.72% |
| 2011-10-31 | 31.20% |
| 2011-07-31 | 35.76% |
| 2011-04-30 | 42.06% |
| 2011-01-31 | 39.82% |
| 2010-10-31 | 30.06% |
| 2010-07-31 | 26.25% |
| 2010-04-30 | 27.60% |
| 2010-01-31 | 23.58% |
| 2009-10-31 | 23.69% |
| 2009-07-31 | 23.86% |
| 2009-04-30 | 25.08% |
| 2009-01-31 | 22.87% |
| 2008-10-31 | 26.48% |
| 2008-07-31 | 19.05% |
| 2008-04-30 | 20.06% |
| 2008-01-31 | 17.25% |
| 2007-10-31 | 1.32% |
| 2007-07-31 | 15.85% |
| 2007-04-30 | 2.05% |
| 2007-01-31 | 0.00% |
| 2006-10-31 | 73.06% |
| 2006-07-31 | 0.00% |
| 2006-04-30 | 0.00% |
| 2006-01-31 | 0.00% |
